Suchergebnisse - "Barbanti, Fabrizio"

PubPharm (8)

1

Characterization of Clostridium difficile PCR-ribotype 018 : A problematic emerging type

enthalten in: Anaerobe | 2016

von Barbanti, F. | Spigaglia, P.

2

Fluoroquinolone resistance does not impose a cost on the fitness of Clostridium difficile in vitro

enthalten in: Antimicrobial agents and chemotherapy | 2015

von Wasels, F. | Kuehne, S. | Cartman, S. | +4

3

Multidrug resistance in European Clostridium difficile clinical isolates

enthalten in: The Journal of antimicrobial chemotherapy | 2011

von Spigaglia, P. | Barbanti, F. | Mastrantonio, P. | +17

4

Surface layer protein A variant of Clostridium difficile PCR-ribotype 027

enthalten in: Emerging infectious diseases | 2011

von Spigaglia, P. | Barbanti, F. | Mastrantonio, P.

5

Clostridium difficile isolates resistant to fluoroquinolones in Italy : emergence of PCR ribotype 018

enthalten in: Journal of clinical microbiology | 2010

von Spigaglia, P. | Barbanti, F. | Dionisi, A. | +1

6

Detection of gyrA and gyrB mutations in Clostridium difficile isolates by real-time PCR

enthalten in: Molecular and cellular probes | 2010

von Spigaglia, P. | Carattoli, A. | Barbanti, F. | +1

7

Molecular analysis of the gyrA and gyrB quinolone resistance-determining regions of fluoroquinolone-resistant Clostridium difficile mutants selected in vitro

enthalten in: Antimicrobial agents and chemotherapy | 2009

von Spigaglia, P. | Barbanti, F. | Louie, T. | +2

8

Fluoroquinolone resistance in Clostridium difficile isolates from a prospective study of C. difficile infections in Europe

enthalten in: Journal of medical microbiology | 2008

von Spigaglia, P. | Barbanti, F. | Mastrantonio, P. | +6

1
[1]